interferon for COVID-19 - live meta-analysis of clinical studies

Study explorer (study characteristics and results) method abbreviations pdf xlsx

display ongoing studies
Study	Ref.	RCT OBS RCT + OBS	studied treatment	control treatment	patients	study risk of bias	sample sizes	Results	deaths E	clinical improvement E	death or ventilation E
COVID-19 severe or critically meta-analysis
Davoudi-Monfared, 2020 IRCT20100228003449N2		RCT	interferon	standard of care	COVID-19 severe or critically	high	46/46	no results
Yekaninejad, 2020 IRCT20100228003449N2		RCT	interferon	standard of care	COVID-19 severe or critically	some concern	33/33	conclusif

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

Study explorer (study characteristics and results) method abbreviations pdf xlsx

COVID-19 severe or critically meta-analysis